InspireMD Net Worth
InspireMD Net Worth Breakdown | NSPR |
InspireMD Net Worth Analysis
InspireMD's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including InspireMD's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of InspireMD's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform InspireMD's net worth analysis. One common approach is to calculate InspireMD's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares InspireMD's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing InspireMD's net worth. This approach calculates the present value of InspireMD's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of InspireMD's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate InspireMD's net worth. This involves comparing InspireMD's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into InspireMD's net worth relative to its peers.
To determine if InspireMD is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding InspireMD's net worth research are outlined below:
InspireMD had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 6.21 M. Net Loss for the year was (19.92 M) with profit before overhead, payroll, taxes, and interest of 1.12 M. | |
InspireMD currently holds about 26.47 M in cash with (16.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
InspireMD uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in InspireMD. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to InspireMD's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024 Upcoming Quarterly Report | View | |
20th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
4th of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Follow InspireMD's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 72.25 M.Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific InspireMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on InspireMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases InspireMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Roubin Gary S over a week ago Acquisition by Roubin Gary S of 30625 shares of InspireMD at 1.3827 subject to Rule 16b-3 | ||
Craig Shore over three months ago Acquisition by Craig Shore of 72978 shares of InspireMD subject to Rule 16b-3 | ||
Kester Thomas J over three months ago Acquisition by Kester Thomas J of 11098 shares of InspireMD at 3.14 subject to Rule 16b-3 | ||
Berman Michael over six months ago Disposition of 61249 shares by Berman Michael of InspireMD at 1.3827 subject to Rule 16b-3 | ||
Stuka Paul over six months ago Disposition of 87500 shares by Stuka Paul of InspireMD at 1.3827 subject to Rule 16b-3 | ||
Paul Stuka over six months ago Acquisition by Paul Stuka of 43548 shares of InspireMD subject to Rule 16b-3 | ||
Verta Patrick over a year ago InspireMD exotic insider transaction detected | ||
Paul Stuka over a year ago Acquisition by Paul Stuka of 238950 shares of InspireMD subject to Rule 16b-3 | ||
Paul Stuka over a year ago Acquisition by Paul Stuka of 225680 shares of InspireMD subject to Rule 16b-3 |
InspireMD Earnings per Share Projection vs Actual
InspireMD Corporate Management
Shane Gleason | Chief Officer | Profile | |
Roei Samuri | VP Operations | Profile | |
DVM MD | Executive Affairs | Profile | |
Andrea Tommasoli | Chief Officer | Profile | |
Amir Kohen | Vice Resources | Profile |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.